🔎 Trials Near Me

Hjem › Fedme › Kentucky › Louisville

Kliniske studier for Fedme i Louisville, KY

17 studier for Fedme søker deltakere på steder i og rundt Louisville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville
Alder 18 til 99 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07684235

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • L-MARC Research Center /ID# 282008, Louisville
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07752979

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RekruttererFase 3
  • Monroe Biomedical Research, Louisville
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Gastroenterology Health Partners, Louisville
  • Gastroenterology Health Partners, New Albany · 4 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • Norton Children's Endocrinology, Louisville
Alder 6 til 17 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Gastroenterology Health Partners, Louisville
  • Gastroenterology Health Partners, New Albany · 4 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937086

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekruttererFase 3
  • Monroe Biomedical Research - Louisville, Louisville
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Monroe Biomedical Research - Louisville, Louisville
Alder 18 til 75 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • Monroe Biomedical Research, Louisville
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

RekruttererFase 3
  • L-MARC Research Center, Louisville
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Monroe Biomedical Research - Louisville, Louisville
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06143956

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekruttererFase 3
  • UofL Health Care Outpatient, Louisville
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

RekruttererFase 3
  • Monroe Biomedical Research, LLC, Louisville
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekruttererFase 3
  • ACCOMPLISH-1 Research Site, Louisville
Alder 18 til 79 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

RekruttererFase 2
  • L-MARC Research Center, Louisville
Alder 18 til 80 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07477704

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

RekruttererFase 2
  • Monroe Biomedical Research, Louisville
Alder 18 til 60 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT07570758

Adrenergic Cholinergic Enteric Measures/Mapping

RekruttererObservasjonsstudie
  • University of Louisville, Louisville
Alder 10 til 80 · Alle kjønn · Oppdatert 10. jan. 2025 · NCT04013282

Fedme-studier i andre byer

Andre studier i Louisville

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.